Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

Nature

Volumn 491, Issue 7423, 2012, Pages 264-268

  Yoshizaki, Ayumi ^a   Miyagaki, Tomomitsu ^a   Dilillo, David J ^a   Matsushita, Takashi ^a   Horikawa, Mayuka ^a   Kountikov, Evgueni I ^a   Spolski, Rosanne ^b   Poe, Jonathan C ^a   Leonard, Warren J ^b   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 21;

ANTIBODY; ANTIGEN; CELL ORGANELLE; IMMUNE RESPONSE; IMMUNITY; INHIBITION; INHIBITOR; RODENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; EX VIVO STUDY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD40; ANTIGENS, CD5; AUTOIMMUNITY; B-LYMPHOCYTES, REGULATORY; CELL DIVISION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-10; INTERLEUKINS; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-21; T-LYMPHOCYTES;

MUS;

EID: 84868619716     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11501     Document Type: Article

References (37)

1. LeBien, T. W.& Tedder, T. F. B-lymphocytes: how they develop and function. Blood 112, 1570-1580 (2008).
2. DiLillo, D. J., Matsushita, T. & Tedder, T. F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. NY Acad. Sci. 1183, 38-57 (2010).
3. Fillatreau, S. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240, 52-71 (2011).
4. Mauri, C. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22, 761-767 (2010).
5. Iwata, Y. et al. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530-541 (2011).
6. Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD51 phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639-650 (2008).
7. Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420-3430 (2008).
8. Ray, A., Basu, S., Williams, C. B., Salzman, N. H. & Dittel, B. N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188, 3188-3198 (2012).
9. Yanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T. & Tedder, T. F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182, 7459-7472 (2009).
10. Haas, K. M. et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 184, 4789-4800 (2010).
11. Matsushita, T., Horikawa, M., Iwata, Y. & Tedder, T. F. Regulatory B cells (B10 cells) andregulatory T cells have independent roles in controlling EAE initiation and latephase immunopathogenesis. J. Immunol. 185, 2240-2252 (2010).
12. Horikawa, M., Minard-Colin, V., Matsushita, T. & Tedder, T. F. Regulatory B cell production of IL-10 inhibits lymphomadepletion duringCD20immunotherapy in mice. J. Clin. Invest. 121, 4268-4280 (2011).
13. Maseda, D. et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 188, 1036-1048 (2012).
14. Spolski, R.&Leonard, W. J. IL-21and T follicular helper cells. Int.Immunol. 22, 7-12 (2009).
15. Linterman, M. A. & Vinuesa, C. G. T follicular helper cells during immunity and tolerance. Prog. Mol. Biol. Transl. Sci. 92, 207-248 (2010).
16. Ettinger, R. et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175, 7867-7879 (2005).
17. Ozaki, K. et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173, 5361-5371 (2004).
18. Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298, 1630-1634 (2002).
19. Spolski, R., Kim, H. P., Zhu, W., Levy, D. E. & Leonard, W. J. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182, 2859-2867 (2009).
20. Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797-801 (2009).
21. Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081 (2003).
22. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
23. Chen, G. et al. Regulation of the IL-21 gene by the NF-kB transcription factor c-Rel. J. Immunol. 185, 2350-2359 (2010).
24. Poe, J. C. et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 6, e22464 (2011).
25. Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nature Comm. 2, 465 (2011).
26. Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682 (1988).
27. Coquet, J. M., Chakravarti, S., Smyth, M. J. & Godfrey, D. I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180, 7097-7101 (2008).
28. Hoehlig, K. et al. Activation ofCD41 Foxp31 regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 42, 1164-1173 (2012).
29. Weber, M. S. et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nature Med. 13, 935-943 (2007).
30. Matsushita, T.&Tedder, T. F. Identifying regulatoryBcells (B10cells) that produce IL-10. Methods Mol. Biol. 677, 99-111 (2011).
31. Kühn, R., Lohler, J., Rennick, D., Rajewsky, K.& Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
32. Grusby, M. J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913-3917 (1993).
33. Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S. & Tedder, T. F. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157, 4371-4378 (1996).
34. Sato, S., Steeber, D. A., Jansen, P. J. & Tedder, T. F. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158, 4662-4669 (1997).
35. Zhou, L.-J. et al. Tissue-specific expression of the humanCD19gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol. Cell. Biol. 14, 3884-3894 (1994).
36. Tedder, T. F., Wagner, N. & Engel, P. in Leukocyte Typing V: White Cell Differentiation Antigens Vol. 1 (eds Schlossman, S. F. et al.) 483-504 (Oxford Univ. Press, 1995).
37. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulateautoimmunitybyprovisionof IL-10.Nature Immunol. 3,944-950(2002).